Cytokine and Growth Factor Responses After Radiotherapy for Localized Ependymoma

International Journal of Radiation Oncology Biology Physics

Volumn 74, Issue 1, 2009, Pages 159-167

  Merchant, Thomas E ^a   Li, Chenghong ^a   Xiong, Xiaoping ^a   Gaber, M Waleed ^b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Central nervous system tumors; Cytokines; Ependymoma; Pediatrics; Radiotherapy

Indexed keywords

ANGIOGENESIS; CENTRAL NERVOUS SYSTEM TUMORS; CHEMOATTRACTANT; CYTOKINE; CYTOKINES; EPENDYMOMA; EPIDERMAL GROWTH FACTORS; FIBROBLAST GROWTH FACTORS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTORS; GROWTH FACTORS; INTERFERON-; MACROPHAGE INFLAMMATORY PROTEINS; PEDIATRIC PATIENTS; PEPTIDE GROWTHS; POSTOPERATIVE RADIOTHERAPIES; SUPRATENTORIAL TUMORS; SURGICAL PROCEDURES; TIME COURSE; TREATMENT FAILURES; TUMOR CONTROLS; TUMOR NECROSIS FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTORS; VENTRICULOPERITONEAL;

AMINES; BIOACTIVITY; CELL CULTURE; DISEASE CONTROL; DOSIMETRY; GLYCOPROTEINS; GROWTH (MATERIALS); GROWTH KINETICS; MACROPHAGES; ONCOLOGY; PEDIATRICS; PEPTIDES; RADIOTHERAPY;

TUMORS;

CYTOKINE; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADOLESCENT; ADULT; ARTICLE; BRAIN VENTRICLE PERITONEUM SHUNT; CHILD; CLINICAL ARTICLE; EPENDYMOMA; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; TREATMENT FAILURE; TREATMENT RESPONSE; TUMOR LOCALIZATION;

ADOLESCENT; ANALYSIS OF VARIANCE; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; CYTOKINES; EPENDYMOMA; FEMALE; HUMANS; INFANT; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-8; MALE; NEOPLASM PROTEINS; RADIOTHERAPY, CONFORMAL; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 64049095598     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.07.058     Document Type: Article

References (31)

1. Central Brain Tumor Registry of the United States. Statistical report: Primary brain tumors in the United States, 1995-1999 (2002), Central Brain Tumor Registry of the United States, Chicago
2. Merchant T.E., Mulhern R.K., Krasin M.J., et al. Preliminary results from a phase II trial of conformal radiation therapy and evaluation of radiation-related CNS effects for pediatric patients with localized ependymoma. J Clin Oncol 22 (2004) 3156-3162
3. Merchant T.E., and Fouladi M. Ependymoma: New therapeutic approaches including radiation and chemotherapy. J Neurooncol 75 (2005) 287-299
4. Hong J.H., Chiang C.S., Campbell I.L., et al. Induction of acute phase gene expression by brain irradiation. Int J Radiat Oncol Biol Phys 33 (1995) 619-626
5. Kyrkanides S., Olschowka J.A., Williams J.P., et al. TNF alpha and IL-1beta mediate intercellular adhesion molecule-1 induction via microglia-astrocyte interaction in CNS radiation injury. J Neuroimmunol 95 (1999) 95-106
6. Gaber M.W., Sabek O.M., Fukatsu K., et al. Differences in ICAM-1 and TNF-alpha expression between large single fraction and fractionated irradiation in mouse brain. Int J Radiat Biol 79 (2003) 359-366
7. Yuan H., Gaber M.W., McColgan T., et al. Radiation-induced permeability and leukocyte adhesion in the rat blood-brain barrier: modulation with anti-ICAM-1 antibodies. Brain Res 969 (2003) 59-69
8. Vignali D.A.A. Multiplexed particle-based flow cytometric assays. J Immunologic Methods 243 (2000) 243-255
9. Kellar K.L., Kalwar R.R., Dubois K.A., et al. Multiplexed fluorescent bead-based immunoassays for quantitation of human cytokines in serum and culture supernatants. Cytometry 45 (2001) 27-36
10. Hosmer D.W., and Lemeshow S. Applied logistic regression. 2nd ed. (2000), Wiley & Sons, New York
11. Madani I., De R.K., Goeminne H., et al. Predicting risk of radiation-induced lung injury. J Thorac Oncol 2 (2007) 864-874
12. Kureshi S.A., Hofman F.M., Schneider J.H., et al. Cytokine expression in radiation-induced delayed cerebral injury. Neurosurgery 35 (1994) 822-829
13. Gridley D.S., Loredo L.N., Slater J.D., et al. Pilot evaluation of cytokine levels in patients undergoing radiotherapy for brain tumor. Cancer Detect Prev 22 (1998) 20-29
14. Li A., Dubey S., Varney M.L., et al. IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol 170 (2003) 3369-3376
15. Li A., Varney M.L., Valasek J., et al. Autocrine role of interleukin-8 in induction of endothelial cell proliferation, survival, migration and MMP-2 production and angiogenesis. Angiogenesis 8 (2005) 63-71
16. Schraufstatter I.U., Trieu K., Zhao M., et al. IL-8-mediated cell migration in endothelial cells depends on cathepsin B activity and transactivation of the epidermal growth factor receptor. J Immunol 171 (2003) 6714-6722
17. Gaugler M.H., Vereycken-Holler V., Squiban C., et al. Pravastatin limits endothelial activation after irradiation and decreases the resulting inflammatory and thrombotic responses. Radiat Res 163 (2005) 479-487
18. Osuka K., Suzuki Y., Saito K., et al. Changes in serum cytokine concentrations after neurosurgical procedures. Acta Neurochir (Wien) 138 (1996) 970-976
19. Criscuolo G.R., Merrill M.J., and Oldfield E.H. Further characterization of malignant glioma-derived vascular permeability factor. J Neurosurg 69 (1988) 254-262
20. Takano S., Yoshii Y., Kondo S., et al. Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res 56 (1996) 2185-2190
21. Stockhammer G., Obwegeser A., Kostron H., et al. Vascular endothelial growth factor (VEGF) is elevated in brain tumor cysts and correlates with tumor progression. Acta Neuropathol 100 (2000) 101-105
22. Ribom D., Larsson A., Pietras K., et al. Growth factor analysis of low-grade glioma CSF: PDGF and VEGF are not detectable. Neurol Sci 24 (2003) 70-73
23. Salven P., Manpaa H., Orpana A., et al. Serum vascular endothelial growth factor is often elevated in disseminated cancer. Clin Cancer Res 3 (1997) 647-651
24. Bruce J.N., Criscuolo G.R., Merrill M.J., et al. Vascular permeability induced by protein product of malignant brain tumors: Inhibition by dexamethasone. J Neurosurg 67 (1987) 880-884
25. Pietsch T., Valter M.M., Wolf H.K., et al. Expression and distribution of vascular endothelial growth factor protein in human brain tumors. Acta Neuropathol 93 (1997) 109-117
26. Preusser M., Wolfsberger S., Haberler C., et al. Vascularization and expression of hypoxia-related tissue factors in intracranial ependymoma and their impact on patient survival. Acta Neuropathol 109 (2005) 211-216
27. Chan A.S., Leung S.Y., Wong M.P., et al. Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma. Am J Surg Pathol 22 (1998) 816-826
28. Korshunov A., Golanov A., and Timirgaz V. Immunohistochemical markers for prognosis of ependymal neoplasms. J Neurooncol 58 (2002) 255-270
29. Merchant T.E., Lee H., Zhu J., et al. The effects of hydrocephalus on intelligence quotient in children with localized infratentorial ependymoma before and after focal radiation therapy. J Neurosurg 101 2 Suppl (2004) 159-168
30. Gisterek I., Sedlaczek P., Kornafel J., et al. Serum vascular endothelial growth factor in patients with pharyngeal and laryngeal squamous cell carcinoma treated with radiotherapy. Am J Otolaryngol 28 (2007) 73-77
31. Bussink J., and Kaanders J.H. van der Kogel AJ. Microenvironmental transformations by VEGF- and EGF-receptor inhibition and potential implications for responsiveness to radiotherapy. Radiother Oncol 82 (2007) 10-17